Gastrointestinal surgery for severe obesity

Nutrition

Volumn 12, Issue 6, 1996, Pages 403-404

  Brolin, Robert E ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENFLURAMINE; PHENTERMINE RESIN; PLACEBO;

BILIOPANCREATIC BYPASS; CLINICAL TRIAL; CONFERENCE PAPER; GALLSTONE; GASTROINTESTINAL SURGERY; GASTROPLASTY; HUMAN; LAPAROSCOPIC SURGERY; OBESITY; PATIENT SELECTION; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR; STOMACH BYPASS; WEIGHT REDUCTION; ABDOMINAL SURGERY; ADOLESCENT; CHILD; FEMALE; MORBID OBESITY; REVIEW;

ADOLESCENT; BILIOPANCREATIC DIVERSION; CHILD; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; HUMANS; OBESITY, MORBID; PREGNANCY; RISK FACTORS;

EID: 0030155575     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-9007(96)00154-2     Document Type: Conference Paper

References (13)

1. Gastrointestinal surgery for severe obesity. NIH Consensus Development Conference. Consensus Statement. 1991 Mar 25-27;9(1)
2. Marcus MD, Wing RR, Ewing L, Kern E, McDermott M, Gooding W. A double-blind, placebo-controlled trial of fluoxetine plus behavior modification in the treatment of obese binge-eaters and non-binge-eaters. Am J Psychiatry 1990;147:876
3. Weintraub M, Hasday JD, Mushlin AI, Lockwood DH. A double blind clinical trial in weight control: Use of fenfluramine and phentermine alone and in combination. Arch Intern Med 1984;144:1143
4. Weintraub M. Long term weight control: The National Heart, Lung and Blood Institute funded multimodal intervention study. Clin Pharmacol Ther 1992;51:581
5. Rand CSW, MacGregor AMC. Adolescents having obesity surgery: A 6-year follow up. Southern Med J 1994;87:1208
6. Printen KJ, Scott DS. Pregnancy following gastric bypass for the treatment of morbid obesity. Am Surg 1982;48:363
7. Deitel M. Gynecologic-obstetrics changes after massive weight loss. Abstract presented at the Third Annual Meeting of the American Society for Bariatric Surgery, Iowa City, 1A, June 19, 1986
8. Sugerman HJ, Brewer WH, Schiffman ML, et al. A multicenter, placebo-controlled randomized, double-blind prospective trial of Ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss. Am J Surg 1995;169:91
9. Scopinaro N, Gianetta E, Friedman D, et al. Biliopancreatic diversion for obesity. Problems in General Surgery. 1992;9:362
10. Marceau P, Biron S, Bourgue RA, et al. Biliopancreatic diversion with a new type of gastrectomy. Obes Surg 1993;3:29
11. Considine RV, Considine EL, Williams CJ, et al. Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity. J Clin Invest 1995;95:2986
12. Pories WJ, MacDonald KG, Flickinger EG, et al. Is Type II Diabetes Mellitus (NIDDM) a surgical disease? Ann Surg 1992;215:634
13. Pories WJ, Caro JF, Flickinger EG, et al. The control of diabetes mellitus (NIDDM) in the morbidly obese with the Greenville gastric bypass. Ann Surg 1987;206:316